Skip Navigation LinksHome > Published Ahead-of-Print > Tumor Lysis Syndrome: An Unreported Complication of Intrath...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0000000000000188
Clinical and Laboratory Observations: PDF Only

Tumor Lysis Syndrome: An Unreported Complication of Intrathecal Ara-C.

Simangan, Lenore R. MD; Kline, Ronald M. MD

Published Ahead-of-Print
Collapse Box

Abstract

Intrathecal (IT) chemotherapy is an established method of preventing and treating CNS leukemia. Although this intervention is beneficial and necessary, understanding the potential adverse effects of IT chemotherapy is important so that these potential effects can be anticipated and prevented. Tumor lysis syndrome is a known complication of systemic chemotherapy and has also been reported as a rare complication after IT chemotherapy in patients with CNS disease. We report the first case of tumor lysis syndrome occurring in a patient with T-cell acute lymphoblastic leukemia without CNS disease. The systemic effects of the IT chemotherapy were confirmed by the decreased size of the presenting mediastinal mass.

(C) 2014 by Lippincott Williams & Wilkins.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.